ATS 2019 Virtual Final Program

Facilitator : E.A. Nardell, MD, Boston, MA P41 The Burden of HIV/AIDS and Tuberculosis Co-Infection in East Asia and the Pacific from 1990-2016: Findings from the Global Burden of Disease Study/ J. Zhang, T. Yu, S. Kern-Allely, St. Louis, MO, p.A5145 P42 Prevalence of Tuberculosis and Its Factors Among Patients on Maintenance Dialysis in Douala, Cameroon/ B.H. Mbatchou Ngahane, S. Gaping Simen, M.P. Halle, C. Okalla, I.A. Goupeyou Wandji, Douala, Cameroon, p.A5146 P43 Household Air Pollution as a Trigger of Chronic Cough After Completion of Mycobacterium Tuberculosis Treatment in Rural Democratic Republic of Congo/ P.D.M.C. Katoto, T. Kayembe-Kitenge, A. Murhula, B. Kirenga, B. Casinga, P. De Boever, Z. Kashongwe, H.B. Lawin, S.G. Mfinanga, K.J. Mortimer, T. Nawrot, J. Nachega, B. Nemery, Bukavu, Congo, Democratic Republic of the, p.A5147 P44 Active Tuberculosis in Patients Receiving Renal Replacement Therapy for End Stage Renal Disease/ K. Shah, E. Johnson, A. Rahman, K. McCaffferty, H. Kunst, London, United Kingdom, p.A5148 P45 Gene Xpert Assay Utilization for Early Diagnosis of TB Disease at Houston Methodist Hospital/ S. Agarwal, D.T.M. Nguyen, E. Graviss, Houston, TX, p.A5149 P46 Multi Drug Resistant Tuberculosis at Dr Zainoel Abidin Hospital (A Case Study After 13 Years of Tsunami Disaster in Aceh)/ M. Mulyadi, R. Mulia, T. Mamfaluti, Banda Aceh, Indonesia, p.A5150 Facilitator : C. Yoon, MD, MPH, MSCR, San Francisco, CA P47 In Pulmonary Tuberculosis Direct Smear Sputum Is a Prognostic Factor for Cure/ J.A. Leon-Abarca, R.A. Accinelli Tanaka, M. Lopez, J. Ascarza, Lima, Peru, p.A5151 P48 Primary Cases Among Drug Resistant Tuberculosis in Dr. Soetomo Hospital Surabaya, Indonesia/ T. Kusmiati, S. Soedarsono, E. Burhan, Surabaya, Indonesia, p.A5152 P49 Diabetes Mellitus Increases Risk of Multi-Drug Resistant Tuberculosis in Jakarta, Indonesia/ I. Fajarwati, D. Handayani, E. Burhan, Jakarta Timur, Indonesia, p.A5153 P50 The Risk of Tuberculosis and Other Infections in Diabetic Patients Using Statins Versus Nonstatin Lipid-Lowering Agents/ S.-W. Pan, Y.-J. Chan, W.-J. Su, Taipei, Taiwan, p.A5154 P51 Body Mass Index in Children with Tuberculosis /L. Gorbach, Minsk, Belarus, p.A5156 Facilitator: J.J. Saukkonen, MD, West Roxbury, MA P52 Relative Risks of Pulmonary Tuberculosis in Children and Adolescents with Upper Respiratory Tract Infections/ L. Gorbach, Minsk, Belarus, p.A5157 P53 Changes in Tuberculosis Disease Burden Among South African Adolescents, 2005-2015/ E.W. Bunyasi, H. Mulenga, A. Luabeya, J. Shenje, S. Mendelsohn, M. Tameris, E. Nemes, R. Wood, T. Scriba, M. Hatherill, Cape Town, South Africa, p.A5158 P54 Activity Report of a Multi-Drug Resistant Tuberculosis Unit of Dakar/ F.B.R. Mbaye, A. Niang, N.O. Touré, N.A. Ndoye, K. Thiam, Dakar, Senegal, p.A5159 P55 Burden and Clinical Characteristics of High Grade Tuberculosis-Destroyed Lung: A Nationwide Study/ D. Han, C.K. Rhee, Y.-M. Oh, Seoul, Korea, Republic of, p.A5160 P56 Latent Tuberculosis Infection (LTBI) in the Private Healthcare Sector: Do Persons with LTBI Have Health Insurance and Usual Sources of Healthcare?/ E. Annan, E.L. Stockbridge, T.L. Miller, Fort Worth, TX, p.A5161 P57 The Situation of Mortality and Burden of Tuberculosis at Some Hospitals in Vietnam in 2015/ N.A.T. Le ,T.Q. Bui, B.H Nguyen, C.K. Nguyen, Bui, H.T.T., N.V. Nguyen, Ha Noi, Vietnam, p.A5162 BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION C55 TUBERCULOSIS DIAGNOSIS 9:15 a.m. - 4:15 p.m. KBHCCD Area A (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitator : D.L. Cohn, MD, Denver, CO P60 A Bacteriophage-Based Method Identifies Low Level Mycobacterium Tuberculosis Bacteraemia in Immunocompetent Patients with Active and Incipient Disease/ R. Verma, B. Swift, W. Headley, J. Lee, C. Rees, P. Haldar, Leicester, United Kingdom, p.A5163 P61 Higher Interferon-gamma (IFN-gamma) Antigen Responses Among US Adults with Pre-Diabetes and Latent Tuberculosis Infection: Findings from the National Health and Nutrition Examination Survey, 2011-2012/ S. Trost, C. Day, A. Salindri, G. Amere, N. Gandhi, M. Magee, Atlanta, GA, p.A5164 P62 Frequency of Herero-Resistance to First- and Second-Line Anti-Tuberculosis (TB) Drugs in a Population-Based Sample of Drug-Resistant TB Patients/ C.A. Berger, C. Allender, M.N. Hunat, A.G. Sedusta, C.A. Sacopon, J. Sabalboro, J.E. Bascuña, B. Schwem, A. Dela Tonga, M.C. Ama, R. Destura, A. Cattamanchi, M. Kato-Maeda, San Francisco, CA, p.A5165 P63 Time to Retire Acid Fast Bacilli Smears? Superiority of Newer Assays in Ruling Out Pulmonary Tuberculosis/ A. Hickey, I.K. Louh, J. Li, M.R. O’Donnell, New York, NY, p.A5166 P64 An Individual Patient Data Meta-Analysis to Estimate the Diagnostic Accuracy of a Machine Learning-Based Software for Analyzing Chest X-Rays of Persons with Symptoms of Pulmonary Tuberculosis: Preliminary Findings/ S.K. Abidi, M. Harris, M. Muyoyeta, K. Dheda, A. Esmail, K. Reiter, M. Breuninger, A. Qi, C. Denkinger, A. Korobitsyn, M. Pai, A. Benedetti, F. Ahmad Khan, Montreal, Canada, p.A5167 ATS 2019 • Dallas, TX 268 TUESDAY • MAY 21